RESUMEN

PurposeOne of the earliest hallmarks of diabetic retinopathy is the loss of retinal pericytes. However, the mechanisms that promote pericyte dropout are unknown. In the present study, we propose a novel pathway in which pericyte apoptosis is mediated by macrophages, TGFß and pro-apoptotic BIGH3 (TGFß-induced Gene Human Clone 3) protein.Patients and methodsTo elucidate this pathway, we assayed human retinal pericyte (HRP) apoptosis by TUNEL assay, BIGH3 mRNA expression by qPCR, and BIGH3 protein expression by western blot analysis. HRP were treated with BIGH3 protein, TGFß1 and TGFß2 and inhibition assays were carried out by blocking with antibodies against BIGH3. The distribution of BIGH3 and CD68+ macrophages were compared in a post-mortem donor eye with 7-year history of Type II diabetes and histopathogically confirmed non-proliferative diabetic retinopathy (NPDR).ResultsTGFß induced a significant increase in BIGH3 mRNA and protein expression, and HRP apoptosis. BIGH3 treatment showed HRP undergo apoptosis in a dose-dependent manner. At 5 µg/ml, BIGH3 induced 3.5-times more apoptosis in HRP than in retinal endothelial cells. TGFß induced apoptosis was inhibited by blocking with antibodies against BIGH3. In an example of NPDR, BIGH3 accumulated within the walls of the inner retina arterioles. Macrophage infiltrates were frequently associated with these vessels and the inner nuclear layer.ConclusionTogether with our previously published results on macrophage-induced retinal endothelial cell apoptosis, the present study supports a novel inflammatory pathway mediated by macrophages and the BIGH3 protein leading to HRP apoptosis. As shown in human post-mortem globes, these observations are clinically relevant, suggesting a new mechanism underlying pericyte dropout during NPDR.

Asunto(s)

Retinopatía Diabética/metabolismo , Proteínas de la Matriz Extracelular/metabolismo , Pericitos/efectos de los fármacos , Retina/metabolismo , Factor de Crecimiento Transformador beta1/farmacología , Factor de Crecimiento Transformador beta2/farmacología , Factor de Crecimiento Transformador beta/metabolismo , Antígenos CD/metabolismo , Antígenos de Diferenciación Mielomonocítica/metabolismo , Arteriolas/metabolismo , Western Blotting , Células Cultivadas , Diabetes Mellitus Tipo 2/complicaciones , Retinopatía Diabética/patología , Proteínas de la Matriz Extracelular/farmacología , Humanos , Macrófagos/citología , Pericitos/patología , Reacción en Cadena de la Polimerasa , ARN Mensajero/metabolismo , Retina/patología , Vasos Retinianos/metabolismo , Factor de Crecimiento Transformador beta/farmacología

Asunto(s)

Hipocampo/fisiología , Potenciación a Largo Plazo/fisiología , Oligopéptidos/farmacología , Animales , Electrofisiología , Hipocampo/efectos de los fármacos , Masculino , Ratas , Ratas Sprague-Dawley , Transmisión Sináptica/efectos de los fármacos , Transmisión Sináptica/fisiología , Ritmo Teta/efectos de los fármacos , Factores de Tiempo

RESUMEN

As the ability to understand the peculiarities of successful healing of articular cartilage defects moves forward, it becomes clear that this complex orthopaedic problem soon will be successfully addressed. A multidisciplinary approach, combining clinical experience, cogent biomaterial designs, new cell biologic processes, biomechanical assessment, and modern molecular biology, clearly is leading toward clinically acceptable, viable, and consistent articular cartilage regeneration.

Asunto(s)

Enfermedades de los Cartílagos/fisiopatología , Enfermedades de los Cartílagos/terapia , Cartílago Articular/fisiopatología , Articulación de la Rodilla/fisiopatología , Cicatrización de Heridas , Fenómenos Biomecánicos , Proteínas Morfogenéticas Óseas/uso terapéutico , Cartílago Articular/lesiones , Cartílago Articular/trasplante , Quitina/análogos & derivados , Quitina/uso terapéutico , Quitosano , Condrogénesis , Colágeno/uso terapéutico , Adhesivo de Tejido de Fibrina/uso terapéutico , Factores de Crecimiento de Fibroblastos/uso terapéutico , Humanos , Ácido Hialurónico/uso terapéutico , Regeneración , Sefarosa/uso terapéutico , Trasplante de Células Madre

RESUMEN

We have previously demonstrated that peritumoral stromal matrix derived from prostate cancer patients who relapse after radical surgery contains elevated levels of versican. The purpose of this study was to determine whether prostate cancer cells control stromal cell secretion of versican. Serum-free conditioned medium from three prostate adenocarcinoma cell lines, LNCaP, PC3, and DU145, was added to cultures of fibroblasts established from prostatic tissue of patients with benign prostatic hyperplasia, and the medium was harvested at 24, 48, and 72 h. Immunoblotting with an antiversican core protein antibody revealed that prostatic fibroblast medium harvested at 72 h contained increased levels of versican after treatment with either LNCaP-, PC3- or DU145-conditioned medium (2.5-, 4.5-, and 5-fold, respectively) compared with control cultures. This increase in versican in the culture medium was not observed after coincubation with transforming growth factor beta1-neutralizing antisera. The results of this study suggest that prostate tumor cells induce host stromal cells to secrete increased versican levels via a paracrine mechanism mediated by transforming growth factor beta1.

Asunto(s)

Adenocarcinoma/metabolismo , Proteoglicanos Tipo Condroitín Sulfato/biosíntesis , Próstata/metabolismo , Neoplasias de la Próstata/metabolismo , Factor de Crecimiento Transformador beta/farmacología , Adenocarcinoma/patología , Comunicación Celular/fisiología , División Celular , Células Cultivadas , Proteoglicanos Tipo Condroitín Sulfato/genética , Proteoglicanos Tipo Condroitín Sulfato/metabolismo , Técnicas de Cocultivo , Medios de Cultivo Condicionados , Fibroblastos/citología , Fibroblastos/metabolismo , Humanos , Immunoblotting , Lectinas Tipo C , Masculino , Próstata/citología , Neoplasias de la Próstata/patología , ARN Mensajero/biosíntesis , ARN Mensajero/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Células del Estroma/metabolismo , Factor de Crecimiento Transformador beta/biosíntesis , Factor de Crecimiento Transformador beta1 , Versicanos

RESUMEN

This review discusses modern methods used for the synthesis of articular cartilage ex vivo. The value of culturing articular chondrocytes as a monolayer and in three-dimensional lattices is discussed. Of particular interest are techniques involving seeding of chondrocytes onto synthetic, biodegradable, polymeric scaffolds, and natural materials, such as collagen and agarose. Also discussed is the use of bioreactors to modulate the fluid-flow-induced shear environment of cell-seeded scaffolds. Biodegradable scaffolds are central to the efforts to tissue engineer articular cartilage ex vivo. A review of salient efforts to design and use such scaffolds is presented, along with our thoughts on potential future improvements.

Asunto(s)

Cartílago Articular/crecimiento & desarrollo , Animales , Materiales Biocompatibles

RESUMEN

This review describes research on selected peptide sequences that affect cell adhesion as it applies in orthopedic applications. Of particular interest are the integrin-binding RGD peptides and heparin-binding peptides. The influence of these peptides on cell adhesion is described. Cell adhesion is defined as a sequence of four steps: cell attachment, cell spreading, organization of an actin cytoskeleton, and formation of focal adhesions. RGD sequences clearly influence cell attachment and spreading, whereas heparin-binding sequences appear to be less efficient. Collectively, these sequences appear to promote all steps of cell adhesion in certain cell types. This review also addresses issues related to peptide immobilization, as well as potential complexities that may develop as a result of using these versatile cell-binding sequences. Also described are future directions in the field concerning use of existing and more sophisticated peptide substrata.

Asunto(s)

Moléculas de Adhesión Celular/fisiología , Proteínas de la Matriz Extracelular/fisiología , Secuencia de Aminoácidos , Animales , Materiales Biocompatibles , Ingeniería Biomédica , Adhesión Celular/fisiología , Células del Tejido Conectivo/fisiología , Humanos , Integrinas/fisiología , Oligopéptidos/fisiología , Ortopedia , Péptidos/fisiología , Proteoglicanos/fisiología

RESUMEN

Adhesion of cells to biomaterials or to components of the extracellular matrix is fundamental in many tissue engineering and biotechnological processes, as well as in normal development and tissue maintenance. Many cells on adhesive molecules will spread and form an organized actin cytoskeleton and complex transmembrane signaling regions called focal adhesions. Focal adhesions appear to function as both signaling and stabilizing components of normal adherent cell activity. To better understand adhesion formations between cells and their underlying substrata, we have designed, developed, and utilized a novel 'cytodetachment' methodology to quantify the force required to displace attached cells. We allowed bovine articular chondrocytes to attach and spread on a substratum of either fibronectin, bovine serum albumin, or standard microscope glass. The cytodetacher was then employed to displace the cells from the substratum. Our results demonstrate that a significantly greater force is required to detach cells from fibronectin versus the two other substrata, suggesting that a cell's actin cytoskeleton and perhaps focal adhesions contribute significantly to its mechanical adhesiveness. The cytodetacher allows us to directly measure the force required for cell detachment from a substratum and to indirectly determine the ability of different substrata to support cell adhesion.

Asunto(s)

Adhesión Celular , Técnicas de Cultivo de Célula/instrumentación , Condrocitos/citología , Actinas/metabolismo , Animales , Bovinos , Condrocitos/metabolismo , Fibronectinas/metabolismo , Estrés Mecánico

RESUMEN

Proteoglycans have long been recognized as participating in a number of biological activities ranging from structural roles to regulation of transcription. Versican is a large chondroitin sulfate proteoglycan expressed in several tissues, including the nervous system. Significant progress has been made in the understanding of the molecular structure and biological activity of versican. The progress is largely due to the application of recombinant DNA methodology and the generation of domain-specific anti-versican antibodies. In the central and peripheral nervous system, versican is expressed by glial cells and is implicated in the regulation of cell adhesion, migration, pattern formation, and regeneration.

Asunto(s)

Proteoglicanos Tipo Condroitín Sulfato , Animales , Proteoglicanos Tipo Condroitín Sulfato/química , Proteoglicanos Tipo Condroitín Sulfato/genética , Proteoglicanos Tipo Condroitín Sulfato/fisiología , Proteínas de la Matriz Extracelular/metabolismo , Regulación de la Expresión Génica , Glicoproteínas/química , Glicosaminoglicanos/química , Humanos , Lectinas Tipo C , Distribución Tisular , Versicanos

RESUMEN

Versican is a member of the group of aggregating proteoglycans involved in matrix assembly and structure and in cell adhesion. We examined changes in the distribution of versican in mammalian skin, with emphasis on hair follicle development and cycling. In adult human skin, immunostaining for versican appeared predominantly in the dermis, with intense staining of the reticular dermis. Weak staining was observed at the dermoepidermal junction and the connective tissue sheath of hair follicles. Versican expression was also noted in the reticular dermis of rat skin, within dermal papillae, and possibly associated with follicle basement membranes. During mouse hair follicle development, versican was not expressed until the hair follicles were beginning to produce fibers. With follicle maturation, versican expression intensified in the dermal papillae, reaching a maximum at the height of the growth phase (anagen), after which it diminished as the end of this phase approached. Versican immunoreactivity in the papillae decreased further during catagen and was absent from these structures during telogen. However, intense staining for versican was then observed in the neck regions of telogen follicles. As the follicles entered the next hair cycle, versican disappeared from the necks and was again seen in the dermal papillae when follicles began producing fibers. This type of expression continued throughout subsequent hair cycles and is unlike any other dermal papilla component. The results of this study are consistent with a distinct supportive role for versican in the follicle matrices during hair follicle morphogenesis and cycling.

Asunto(s)

Animales Recién Nacidos/metabolismo , Proteoglicanos Tipo Condroitín Sulfato/fisiología , Matriz Extracelular/metabolismo , Feto/metabolismo , Cabello/embriología , Cabello/crecimiento & desarrollo , Piel/metabolismo , Envejecimiento/metabolismo , Animales , Animales Recién Nacidos/crecimiento & desarrollo , Aorta/metabolismo , Vasos Sanguíneos/metabolismo , Desarrollo Embrionario y Fetal , Cabello/metabolismo , Humanos , Técnicas Inmunológicas , Lectinas Tipo C , Ratones , Ratones Endogámicos , Ratas , Piel/irrigación sanguínea , Versicanos

RESUMEN

BACKGROUND: Chronic sun exposure induces numerous changes in exposed skin; the most striking histopathologic change is the massive accumulation of material with the staining characteristics of elastin, termed solar elastosis, in the superficial dermis. Previous studies have identified elastic fibers within areas of solar elastosis, as well as a decrease in collagen content. Recently, the large chondroitin sulfate (CS) proteoglycan, versican, has been identified in the dermis in association with elastic fibers, and the smaller CS proteoglycan, decorin, has been shown to codistribute with collagen fibers. Thus, changes in expression of these CS proteoglycans might be expected in photoaging and may help to explain the clinical alterations of chronically sun-exposed skin. EXPERIMENTAL DESIGN: Immunohistochemical staining and confocal laser scanning microscopy for versican and decorin was performed on paired tissue samples from photoaged and non-sun-exposed skin taken from the same individuals. To investigate versican and decorin mRNA expression, Northern analysis was performed on paired fibroblast cultures derived from tissue explants of photoaged and non-sun-exposed skin. RESULTS: Immunohistochemical staining and confocal laser scanning microscopy revealed a massive accumulation of versican localized to the abnormally large fibers comprising solar elastosis in the superficial and mid-dermis of photoaged specimens. Decorin staining was greatly decreased within the area of solar elastosis. Similarly, changes in mRNA were measured from fibroblast cultures, with a significant increase in versican mRNA in cultures derived from photoaged skin, whereas decorin mRNA levels were significantly decreased in photoaged skin. CONCLUSIONS: This study provides further evidence for the close association of versican with elastic fibers and decorin with collagen fibers, even in the situation of abnormal fiber deposition occurring in photodamaged skin. In addition, changes in versican and decorin immunostaining are accompanied by similar alterations in gene expression.

Asunto(s)

Proteoglicanos Tipo Condroitín Sulfato/genética , Expresión Génica , Proteoglicanos/genética , Envejecimiento de la Piel/genética , Fenómenos Fisiológicos de la Piel , Anciano , Northern Blotting , Nalgas , Proteoglicanos Tipo Condroitín Sulfato/metabolismo , Decorina , Proteínas de la Matriz Extracelular , Humanos , Inmunohistoquímica , Lectinas Tipo C , Masculino , Microscopía Confocal , Persona de Mediana Edad , Proteoglicanos/metabolismo , Envejecimiento de la Piel/fisiología , Versicanos

RESUMEN

We have previously identified a gene, beta ig-h3, which is highly induced in A549 cells (human lung adenocarcinoma) after growth arrest by transforming growth factor-beta. The beta ig-h3 gene encodes a 683-amino-acid secretory protein termed beta IG-H3, and treatment of several cell lines with transforming growth factor-beta results in increased secretion of beta IG-H3 into cell culture supernatants. In this report, we further characterize beta IG-H3 with respect to its synthesis and function. Primary human foreskin fibroblasts grown in monolayer culture produced beta IG-H3 mRNA and secreted beta IG-H3 protein into the growth media. Treatment of these cells with transforming growth factor-beta led to an increase in beta IG-H3 mRNA and protein. Cells grown on three-dimensional scaffolds secreted beta IG-H3 into the extracellular matrix, as judged by immunostaining with anti-beta IG-H3 antibodies. beta IG-H3 was also detected in normal human skin, especially in the papillary dermis. Finally, we show that recombinant beta IG-H3 supported attachment and spreading of dermal fibroblasts, suggesting that beta IG-H3 may function as an extracellular attachment protein in skin.

Asunto(s)

Proteínas de la Matriz Extracelular , Fibroblastos/citología , Proteínas de Neoplasias/metabolismo , Piel/química , Adulto , Adhesión Celular/efectos de los fármacos , Movimiento Celular/efectos de los fármacos , Células Cultivadas , Fibroblastos/química , Humanos , Recién Nacido , Masculino , Proteínas de Neoplasias/aislamiento & purificación , Proteínas de Neoplasias/farmacología , Piel/citología , Factor de Crecimiento Transformador beta/farmacología

RESUMEN

Rabbit articular chondrocytes were seeded onto three-dimensional polyglycolic acid (PGA) scaffolds and placed into a closed bioreactor system. After 4 weeks of growth, meshes were examined for cartilage formation. Gross examination revealed solid, glistening material that had the appearance of cartilaginous tissue. Histologic examination revealed cell growth and deposition of extracellular matrix throughout the mesh with a less dense central core. Alcian blue and Safranin 0 staining showed deposition of glycosaminoglycans (GAGs). Immunostaining showed positive reactivity for type II collagen and chondroitin sulfate and no reactivity for type I collagen. Biochemical analysis showed collagen and GAG values to be 15% and 25% dry weight, respectively. Our results indicate that this type of system compares well with those previously described and should be useful for producing cartilage for evaluation in a clinical setting. (c) 1995 John Wiley & Sons, Inc.

RESUMEN

A subset of human anti-GM1 ganglioside antibodies cross-reacts with Gal(beta 1-3)GalNAc bearing glycoproteins in peripheral nerve and spinal cord. The same oligosaccharide determinant is recognized by the lectin peanut agglutinin (PNA) which binds at the nodes of Ranvier in intact peripheral nerve. The Gal(beta 1-3)GalNAc bearing glycoproteins were isolated using PNA lectin affinity chromatography followed by separation on Western blot, and the proteins were subjected to partial amino acid sequence analysis. Two major PNA binding glycoproteins were identified in peripheral nerve and spinal cord; one had an approximate molecular weight of 120 kD and had sequence homology to the oligodendrocyte-myelin glycoprotein (OMgp). The other migrated between 70 and 80 kD and had sequence homology to the hyaluronate binding domain of versican, which has been reported to share sequence homology with the 70 kD proteins hyaluronectin and the glial hyaluronic acid binding protein (GHAP). By immunocytochemistry, OMgp was localized to the paranodal region of myelin, and the protein homologous to the hyaluronate binding domain of versican was localized to the nodal gap in peripheral nerve. These PNA binding glycoproteins might be target antigens for autoantibodies in peripheral nerve.

Asunto(s)

Glicoproteínas/análisis , Nervios Periféricos/química , Nódulos de Ranvier/química , Secuencia de Aminoácidos , Western Blotting , Gangliósido G(M1)/inmunología , Glicoproteínas/química , Glicoproteínas/inmunología , Humanos , Inmunohistoquímica , Lectinas , Datos de Secuencia Molecular , Enfermedad de la Neurona Motora/metabolismo , Aglutinina de Mani , Análisis de Secuencia , Médula Espinal/química

RESUMEN

We have previously cloned a large chondroitin sulfate proteoglycan (versican) from human fibroblasts. The primary sequence shows that the N terminus contains sequence homology with known hyaluronate-binding molecule, suggesting that versican can bind hyaluronate. To test this hypothesis we have reconstructed a full-length versican cDNA and a versican cDNA fragment encoding the N terminus and have transfected Chinese hamster ovary cells and mouse 3T3 fibroblasts, respectively, with these constructs. The transfected Chinese hamster ovary cells make a proteoglycan shown to be versican by enzymatic and immunologic analysis. No corresponding proteoglycan was seen in the control cells. Using hyaluronate affinity chromatography, we show that recombinant versican specifically binds hyaluronate and does not bind to heparin or chondroitin sulfate. The transfected fibroblasts make a 78-kDa truncated form of versican that also binds hyaluronate and does not bind the related polysaccharides, showing that the hyaluronate binding activity resides at the N terminus of versican. The binding of versican to hyaluronate is substrate-concentration dependent and time dependent and can be competed with unlabeled versican. The dissociation constant for versican binding to hyaluronate was determined to be 4 x 10(-9) M.

Asunto(s)

Proteoglicanos Tipo Condroitín Sulfato/metabolismo , Ácido Hialurónico/metabolismo , Células 3T3 , Animales , Sitios de Unión , Unión Competitiva , Células CHO , Proteoglicanos Tipo Condroitín Sulfato/genética , Proteoglicanos Tipo Condroitín Sulfato/aislamiento & purificación , Cricetinae , ADN/genética , Electroforesis en Gel de Poliacrilamida , Vectores Genéticos , Humanos , Immunoblotting , Cinética , Lectinas Tipo C , Ratones , Proteínas Recombinantes de Fusión/aislamiento & purificación , Proteínas Recombinantes de Fusión/metabolismo , Tetrahidrofolato Deshidrogenasa/genética , Tetrahidrofolato Deshidrogenasa/metabolismo , Transfección , Versicanos

RESUMEN

The functions and molecular interactions of type V collagen in the pericellular matrix are unclear. Our studies show that type V collagen adsorbed on a surface binds heparin/heparan sulfate with apparent higher affinity than do collagen types I, II, III, IV, or VI, fibronectin, or laminin. Therefore, heparin-like molecules may mediate interactions between cells and type V collagen. Hence, type V collagen may act as an anchor for proteoglycans in the extracellular matrix and function as a substrate for glycosaminoglycan-mediated cell attachment. This model is supported by studies showing that Chinese hamster ovary (CHO) cell mutants which are deficient in glycosaminoglycan synthesis attach poorly to type V collagen substrates compared to wild-type cells, whereas attachment of CHO cell mutants to fibronectin substrates is not affected. Also, exogenous heparin reduces attachment of CHO, endothelial, and smooth muscle cells to type V collagen but does not affect cell attachment to fibronectin. The inhibitory activity of the exogenous heparin/heparan sulfate depends on the size and sulfate content of the polysaccharide chains. At tested concentrations, chondroitin sulfate does not affect the attachment of CHO cells or the binding of biotin-conjugated heparan sulfate to wells coated with type V collagen. These data suggest that a certain degree of structural specificity is involved in glycosaminoglycan binding to type V collagen.

Asunto(s)

Colágeno/metabolismo , Glicosaminoglicanos/metabolismo , Heparitina Sulfato/metabolismo , Secuencia de Aminoácidos , Animales , Biotina , Bovinos , Adhesión Celular , Línea Celular , Cricetinae , Endotelio Vascular/metabolismo , Matriz Extracelular/metabolismo , Fibronectinas/metabolismo , Glicosaminoglicanos/fisiología , Humanos , Laminina/metabolismo , Datos de Secuencia Molecular , Músculo Liso Vascular/metabolismo , Mutación , Proteoglicanos/metabolismo , Ratas

RESUMEN

We have examined the role of cell surface glycosaminoglycans in fibronectin-mediated cell adhesion by analyzing the adhesive properties of Chinese hamster ovary cell mutants deficient in glycosaminoglycans. The results of our study suggest that the absence of glycosaminoglycans does not affect the initial attachment and subsequent spreading of these cells on substrata composed of intact fibronectin or a fibronectin fragment containing the primary cell-binding domain. However, in contrast to wild-type cells, the glycosaminoglycan-deficient cells did not attach to substrate composed of a heparin-binding fibronectin fragment. Furthermore, the wild-type but not the glycosaminoglycan-deficient cells formed F-actin-containing stress fibers and focal adhesions on substrata composed of intact fibronectin. We propose, therefore, that cell surface proteoglycan(s) participate in the transmembrane linking of intracellular cytoskeletal components to extracellular matrix components which occurs in focal adhesions.

Asunto(s)

Adhesión Celular , Fibronectinas/metabolismo , Glicosaminoglicanos/fisiología , Citoesqueleto de Actina/ultraestructura , Animales , Línea Celular , Microscopía de Interferencia , Mutación